Facebook
X
LinkedIn
ForwardEmpowering Excellence in Medical Aesthetics
November 6, 2025 to November 8, 2025
The fields of plastic surgery and medical aesthetics evolve at lightning speed so staying up to date isn’t optional—it’s essential. From new regenerative therapies and exosome applications to advanced injection techniques and cutting-edge technologies. MSP 2025 offers content that aligns with where you are now and where you want to go next. In aesthetics, “what works” is always evolving. New evidence, techniques, and tools surface almost monthly, and the best clinicians know that the difference between staying current and falling behind can come down to patient outcomes, safety, and business performance. MSP 2025 is designed to bridge that gap with sessions built to empower both the clinical and business sides of your career. This annual meeting gives you access to hands-on learning, real-time case analysis, and evidence-backed protocols that elevate your standard of care. Gain access to a full spectrum of plastic surgery and medical aesthetics education, covering essential topics from foundational skills to the latest industry advancements, all crafted to meet the needs of both newcomers and experienced professionals.
Target Audience
This activity is intended to meet the educational needs of the healthcare team including but not limited to:
- Physicians
- Residents
- Medical Students
- Pharmacists
- Physician assistants
- Nurses
- Other Healthcare Professionals
Learning Objectives
After participating in this activity, learners will be able to:
- This annual meeting gives attendees access to hands-on learning, real-time case analysis, and evidence-backed protocols that elevate your standard of care.
- Learn new regenerative therapies and exosome applications to advanced injection techniques and cutting-edge technologies.
- Learn evolving techniques and technologies as it relates to plastic surgery and medical aesthetics.
- Close knowledge gaps that are crucial for ensuring optimal patient outcomes.
Faculty & Disclosure
Disclosure of Relevant Financial Relationships
In accordance with The Standards for Integrity and Independence, GW requires all planners, faculty, and others in control of educational content to disclose the absence or existence of all financial relationships (of any dollar amount) with any ineligible companies within the past 24 months. We define ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
GW reviews all disclosure statements to determine which financial relationships are relevant to the educational content of the CE Activity. An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
Disclosure Statement(s)
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Relevant Financial Relationships
Upon review of all collected information about financial relationships with ineligible companies, GW has determined that the following planners, faculty, and others in control of educational content have relevant financial relationships with ineligible companies.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
● Melissa Beachy, MMS, PA-C, speaker for this accredited CE activity, is an advisor, consultant, speaker, and independent contractor for Allergan Medical Institute.
● Peter Castillo, MD, speaker for this accredited CE activity, is an advisor and speaker for Boston Scientific and is also an advisor, consultant, and has individual stock options at Sciton Lasers and Biote Medical.
● Tara Delle Chiaie, DNP, MSN, speaker for this accredited CE activity, is a trainer for Allergan.
● Michael Kane, MD, speaker for this accredited CE activity, is an advisor, consultant, and individual contractor for Allergan, Galderma, Hugel, Revance, and Teoxane.
● Samiel Lynch, DMSc, DMD, speaker for this accredited CE activity, is a founder of Lynch Regenerative Medicine
● Gary Rubin, PA-C, speaker for this accredited CE activity, is a speaker for Allergan Aesthetics.
● Peter Castillo, MD, speaker for this accredited CE activity, is an advisor and speaker for Boston Scientific and is also an advisor, consultant, and has individual stock options at Sciton Lasers and Biote Medical.
● Tara Delle Chiaie, DNP, MSN, speaker for this accredited CE activity, is a trainer for Allergan.
● Michael Kane, MD, speaker for this accredited CE activity, is an advisor, consultant, and individual contractor for Allergan, Galderma, Hugel, Revance, and Teoxane.
● Samiel Lynch, DMSc, DMD, speaker for this accredited CE activity, is a founder of Lynch Regenerative Medicine
● Gary Rubin, PA-C, speaker for this accredited CE activity, is a speaker for Allergan Aesthetics.
All relevant financial relationships listed for these individual(s) have been mitigated.
All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The George Washington University.
Acknowledgement of Commercial Support
This activity is supported by an educational grant from:
Revance Aesthetics
Accreditation Statements
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement(s)
Physicians (CME)
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 12.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Osteopathic Association (AOA)
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Osteopathic Association (AOA) recognizes AMA PRA Category 1 Credit™ earned as AOA Category 2 credit.
It is the physician's responsibility to report CME credits earned directly to AOA.
Ways to report CME Credit:
- Email: Your CME Certificate to Physician Education & CME at [email protected].
- Online: Via the CME Self-Reporting Tool (login required).
Other Healthcare Professionals (Attendance)
All other healthcare professionals who successfully complete the activity will receive a Certificate of Attendance. Many credentialing bodies such as the ANCC, AANP, and AAPA accept certificates of attendance for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. If you have doubts about whether an activity will qualify for CE, please contact your certifying organization for clarification on credit eligibility.
Available Credit
- 12.00 AMA PRA Category 1 Credit™The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 12.00 Completion
- 12.50 Nursing Hour(s)Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 12.50 hour(s) of continuing nursing education. Educational Review Systems is also approved for nursing continuing education by the state of California (Provider # 14692), the state of Florida and the District of Columbia.
Registration Instructions
Please note that you must be logged in to complete the CE credit claim process.
New Users
You must create a learner account prior to claiming CE credit.
Click here to create a learner account
Click here to access additional instructions for creating a learner account